A detailed history of American Century Companies Inc transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 59,310 shares of AMLX stock, worth $214,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,310
Previous 21,049 181.77%
Holding current value
$214,702
Previous $68,000 227.94%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$2.94 - $7.03 $112,487 - $268,974
38,261 Added 181.77%
59,310 $223,000
Q3 2024

Nov 12, 2024

BUY
$1.65 - $3.24 $3,313 - $6,505
2,008 Added 10.55%
21,049 $68,000
Q2 2024

Aug 07, 2024

SELL
$1.62 - $2.71 $582,806 - $974,941
-359,757 Reduced 94.97%
19,041 $36,000
Q1 2024

May 14, 2024

SELL
$2.71 - $19.57 $443,757 - $3.2 Million
-163,748 Reduced 30.18%
378,798 $1.08 Million
Q4 2023

Feb 13, 2024

BUY
$12.07 - $18.46 $6.55 Million - $10 Million
542,546 New
542,546 $7.99 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $212M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.